Articles written specifically for the GLP or the articles that are reposted from other sources (sometimes in modified form) with permission list the source as Genetic Literacy Project. Excerpted articles list the original media outlet as the source. Excerpts are posted under guidelines for Fair Use and Creative Commons for educational nonprofits (501c3). The GLP’s Fair Use policy for posting excerpts and using images is explained here.
‘Exceptionally potent yet easily scalable’: Synthetic biology-based COVID vaccine could pull ahead of current frontrunners

‘Exceptionally potent yet easily scalable’: Synthetic biology-based COVID vaccine could pull ahead of current frontrunners

Jason Mast | 
Years ago, researchers learned that, when made with biotechnology, some viral proteins could spontaneously assemble themselves into “virus-like particles,” or ...
In a politically divided America, here's how the biotechnology sector sees its future

In a politically divided America, here’s how the biotechnology sector sees its future

Jason Mast | 
[W]hat does Joe Biden’s presidency mean for biopharma? Part of that question will rest on whether Democrats can pull of ...
china

Chinese biopharma firms ‘well ahead’ in race to use CRISPR in humans

John Carroll | 
Contrary to what you might believe, biopharma companies in the US are not the leaders in clinical trials using gene ...
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.